The Valley Desk

ArticleOncoimmunologyPublished

Targeting tumor-selective membrane-associated PCNA enables selective antibody-drug conjugate therapy

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Oncoimmunology
Published
Subject terms
Cell Line, Tumor; Cell Membrane; Animals; Humans; Mice; Neoplasms; Oligopeptides; Immunoglobulin G; Proliferating Cell Nuclear Antigen; Immunoconjugates; Xenograft Model Antitumor Assays; Female
PubMed ID
42873150
PubMed Central ID
PMC13671430
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal